Summary
Increased interest in cardiac safety and renewed interest in drugs for treating myocardial ischemia and congestive heart failure have led to increased use of cardiovascular models. Unfortunately, many molecular or cell-based screens are not perfect predictors of activity in vivo. One rapid means to test “proof of principle” in hearts is the isolated or Langendorff perfused heart system. This allows direct measurement of cardiac contractile function and coronary flow without interference from changes in the systemic circulation. The setup basically is a heart whose coronary arteries are retrogradely perfused through the aortic root with heated and oxygenated buffer solutions. We will describe the constant pressure technique as this is the most commonly used and allows us to directly measure changes in coronary flow without changes in turgor noted with constant flow methods. Instead of a classical working heart preparation, we describe the use of a balloon properly fitted into the left ventricle to measure end diastolic and peak systolic pressure making this a much simpler and less expensive technique without loss of scientific quality. Such a setup can be used to measure effects of compounds or treatments on coronary flow, contractile function either in the normal or pathological states.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Doring H.J. and Dehnert H. (1988) The Isolated Perfused Warm-Blooded Heart according to Langendorff. Biomesstechnik-Verlag March GmbH, West Germany.
Garlid K.D., Paucek P., Yarov-Yarovoy V., Murray H.N., Darbenzio R.B., D’Alonzo A.J., Lodge N.J., Smith M.A., and Grover G.J. (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Circulation 81, 1072–1082.
Atwal K.S., Ferrara F.N., Ding C.Z., Grover G.J., Sleph P.G., Dzwonczyk S., Baird A.J., and Normandin D.E. (1996) Cardioselective antiischemic ATP-sensitive potassium channel openers 4: structure activity studies on benzopyranyl cyano-guanidines; replacement of the benzopyran portion. J. Med. Chem. 39, 304–313.
D’Alonzo A.J., Grover G.J., Darbenzio R.B., Sewter J.C., Hess T.A., Dzwonczyk S., and Sleph. P.G. (1996) Hemodynamic and cardiac effects of BMS-180448, a novel ATP-sensitive potassium channel opener in anesthetized dogs and isolated perfused rat hearts. Pharmacology 52, 101–112.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Grover, G.J., Singh, R. (2007). The Isolated, Perfused Pseudo-Working Heart Model. In: Sreejayan, N., Ren, J. (eds) Vascular Biology Protocols. Methods in Molecular Medicine™, vol 139. Humana Press. https://doi.org/10.1007/978-1-59745-571-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-571-8_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-574-3
Online ISBN: 978-1-59745-571-8
eBook Packages: Springer Protocols